Default company panoramic image
Logo

Renova Therapeutics

Transforming the lives of patients with congestive heart failure

  • Stage Product In Development
  • Industry Biotechnology
  • Location San Diego, CA, USA
  • Currency USD
  • Website renovatherapeutics.com

Company Summary

Renova Therapeutics is developing gene therapy treatments for patients with congestive heart failure. These treatments have the potential to lower the morbidity and mortality from this terrible disease.

Team

  • Default avatar
    Jack Reich
    CEO

    Jack W. Reich, Ph.D. (Co-founder: CEO)
    Collateral Therapeutics (CEO), Myotech, Viagene and Gensia Pharmaceuticals (VP-Regulatory and Quality)-Each of these companies went public and/or were aquired

  • Default avatar
    Kirk Hammond
    Founder and Professor of Medicine

    H. Kirk Hammond, MD (Co-founder: CSO), Professor of Medicine-UCSD, Scientific Founder-Collateral Therapeutics, Selected by the NIH as one of five Centers of Excellence in Gene Therapy in  the USA

  • Default avatar
    Craig Andrews
    Founder and COO

    Craig Andrews (Co-founder:COO), Partner-DLA Piper, Partner-Heller Ehrman, Partner-Brobeck Phleger and Harrison, VP-Airfiber

  • Default avatar
    Roy Cosan
    Board Member

    Roy Cosan-30 plus years of Senior Management at J&J

  • Default avatar
    Andy Noorda
    Board Member

    Andy Noorda- A member of a well known family responsible for the founding and development of a major public tech company